As of April 2024 Aduro Biotech has a market cap of $0.23 Billion. This makes Aduro Biotech the world's 6767th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.23 B | 0% |
2021 | $0.23 B | -0.13% |
2020 | $0.23 B | 148.7% |
2019 | $95.26 M | -54.65% |
2018 | $0.21 B | -63.77% |
2017 | $0.57 B | -24.3% |
2016 | $0.76 B | -57.2% |
2015 | $1.78 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | $11.95 B | 4,953.12% | ๐บ๐ธ USA |
Repligen
RGEN | $9.25 B | 3,809.45% | ๐บ๐ธ USA |
Coherus BioSciences
CHRS | $0.22 B | -3.10% | ๐บ๐ธ USA |
Affimed
AFMD | $74.31 M | -68.59% | ๐ฉ๐ช Germany |